Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
48 other companies have their registered office at the same address; threshold 10.
-
Legal situation KBO
Vrijwillige ontbinding – vereffening according to the CBE.
Financials
Financial year 2025
ARKimedes-Fonds from Brussel, company number BE0874381358, closed financial year 2025 with a result of € -41,466 after tax. Compared with financial year 2024, the result moved from € 1,108 to € -41,466. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 16, 2026.
€ 3.8 million
▼ 1% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -41,466
▼ still € 1,108 profit in 2024
Profit after tax over the fiscal year.
€ 58,363
▼ 67% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -11.7 million.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 2,420
▼ 80% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 8 days on average.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Profit after taxes | € 592,076 | € 662,325 | € 1,108 | € -41,466 | ▼ € 42,575 |
| Equity | € 3,144,169 | € 3,806,494 | € 3,807,602 | € 3,766,136 | ▼ 1% |
| Total debts | € 0 | € 163 | € 12,102 | € 2,451 | ▼ 80% |
| Cash | € 32,330 | € 184,423 | € 178,341 | € 58,363 | ▼ 67% |
| Retained profit | € -12,367,663 | € -11,705,338 | € -11,704,230 | € -11,745,696 | |
| Balance sheet total | € 3,427,638 | € 3,898,641 | € 3,924,071 | € 3,891,240 | ▼ 1% |
Key figures of ARKimedes-Fonds, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to ARKimedes-Fonds?
What happened at ARKimedes-Fonds in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
ARKimedes-Fonds is active according to the CBE. Legal situation: Vrijwillige ontbinding – vereffening.
- New annual accounts for financial year 2025: loss of € 41,466 (▼ € 42,575 vs 2024). Source: NBB ↗
- ARKimedes Management NV became a director. NBB
- New establishment in Brussel. KBO
- Start of the company according to the CBE. KBO
In short
From € 592,076 profit in 2022 to € 41,466 loss in 2025.
Best year ever: 2023, with € 662,325 profit.
Pays suppliers within 8 days on average.
Management
Behind ARKimedes-Fonds is ARKimedes Management NV. It owns 49.9% of Vesalius Biocapital ARKIV (IN VEREFFENING) and 36% of BAEKELAND FONDS II (IN VEREFFENING) itself.
Directors
According to the 2025 annual accounts
Liquidator · represented by Filip Lacquet
since 2020
Establishments
Establishment units
Physical locations of this company
Oude Graanmarkt 63
1000 Brussel
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 48 companies are registered at this address.
All companies at this address →Moeve Chemicals Belgium
€ 1.3 million gross margin · 2025
BIOTECH FONDS VLAANDEREN
Fietsersbond
€ 686,591 gross margin · 2025
Participatiemaatschappij Vlaanderen
€ 16.8 million revenue · 2025
SUSTAINABLE ENERGY VENTURES
+43 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0874.381.358
- VAT number
- BE 0874.381.358
- Registered office
- Oude Graanmarkt 63, 1000 Brussel
- Names & denominations
- ARKimedes-Fonds
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Vrijwillige ontbinding – vereffening
- Start date
- 9 June 2005
- Peppol
- Active · Active since 1 Jan 2001